LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 319

Search options

  1. Article: Effects on the Physical Functioning of Two Exercise Interventions in Patients with Multiple Myeloma: A Pilot Feasibility Study.

    Hillengass, Jens / Hillengass, Michaela / Joseph, Janine M / Attwood, Kristopher / Cannioto, Rikki / Jacobson, Hillary / Miller, Carolyn / Wittmeyer, Bryan / Moysich, Kirsten

    Cancers

    2024  Volume 16, Issue 9

    Abstract: Because of the high prevalence of bone destruction in patients with multiple myeloma (MM), physical exercise is oftentimes discouraged by healthcare providers. The goal of this prospective trial was to investigate the feasibility of two six-month ... ...

    Abstract Because of the high prevalence of bone destruction in patients with multiple myeloma (MM), physical exercise is oftentimes discouraged by healthcare providers. The goal of this prospective trial was to investigate the feasibility of two six-month exercise interventions in patients with MM (
    Language English
    Publishing date 2024-05-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers16091774
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A response to: Vitamin D status may help explain survival disparities among racial/ethnic groups of women with ovarian cancer.

    Stenzel, Ashley E / Moysich, Kirsten B

    Cancer epidemiology

    2019  Volume 64, Page(s) 101650

    MeSH term(s) Continental Population Groups ; Ethnic Groups ; Female ; Humans ; Ovarian Neoplasms ; Registries ; Vitamin D
    Chemical Substances Vitamin D (1406-16-2)
    Language English
    Publishing date 2019-12-04
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 2508729-0
    ISSN 1877-783X ; 1877-7821
    ISSN (online) 1877-783X
    ISSN 1877-7821
    DOI 10.1016/j.canep.2019.101650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: An aspirin a day keeps ovarian cancer at bay?

    Minlikeeva, Albina N / Moysich, Kirsten B

    Expert review of anticancer therapy

    2019  Volume 19, Issue 7, Page(s) 541–542

    MeSH term(s) Aspirin/administration & dosage ; Aspirin/pharmacology ; Cyclooxygenase Inhibitors/administration & dosage ; Cyclooxygenase Inhibitors/pharmacology ; Female ; Humans ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/prevention & control
    Chemical Substances Cyclooxygenase Inhibitors ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2019-06-05
    Publishing country England
    Document type Editorial
    ZDB-ID 2112544-2
    ISSN 1744-8328 ; 1473-7140
    ISSN (online) 1744-8328
    ISSN 1473-7140
    DOI 10.1080/14737140.2019.1626722
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Racial/Ethnic Disparities in Survival Among Women Diagnosed with Invasive Cancer of the Anal Canal: an Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.

    Stenzel, Ashley E / Schlecht, Nicolas F / Moysich, Kirsten B

    Journal of gastrointestinal cancer

    2020  Volume 52, Issue 3, Page(s) 854–862

    Abstract: Objective: To identify differences in survival among women diagnosed with cancer of the anal canal from varying racial and ethnic backgrounds.: Methods: Data from the Surveillance, Epidemiology and End Results (SEER) registry between the years of ... ...

    Abstract Objective: To identify differences in survival among women diagnosed with cancer of the anal canal from varying racial and ethnic backgrounds.
    Methods: Data from the Surveillance, Epidemiology and End Results (SEER) registry between the years of 1975 and 2016 were analyzed, which included 19,048 women with cancer of the anal canal. Multivariable Cox proportional hazard regression (HRs) was performed to examine the relative risk of dying among women with anal cancer. Multivariable odds ratios (ORs) with 95% confidence intervals (CIs) were used to examine odds of highly fatal disease (death within 12 months from diagnosis).
    Results: Non-Hispanic Black women (n = 1694) had greater risk of dying when compared with non-Hispanic White women (n = 15,821) with anal cancer (HR = 1.26, CI: 1.17-1.35), independent of other prognostic indicators. Stratifying by age at diagnosis, risk of death was highest for non-Hispanic Black women diagnosed younger than age 50 years compared with non-Hispanic White women of similar age (HR = 1.60, CI: 1.34-1.89), and lowest for Hispanic women (n = 1533) older than 74 years at diagnosis (HR = 0.80, CI: 0.69-0.92). Stratifying by stage at diagnosis, disparities were not observed. When comparing across years of diagnoses, non-Hispanic Black women consistently had poorer survival compared with non-Hispanic White women diagnosed in the same year intervals. Finally, non-Hispanic Black women had greater odds of highly fatal disease (OR = 1.23, CI: 1.08-1.40) compared with non-Hispanic White women.
    Conclusion: Non-Hispanic Black women with anal cancer continue to experience poorer survival compared with non-Hispanic White women, whereas disparities were not identified for Hispanic women.
    MeSH term(s) Adult ; African Americans/statistics & numerical data ; Aged ; Anus Neoplasms/ethnology ; Anus Neoplasms/mortality ; Ethnicity/statistics & numerical data ; Female ; Hispanic or Latino/statistics & numerical data ; Humans ; Middle Aged ; SEER Program ; United States/epidemiology ; Whites/statistics & numerical data ; Women's Health/ethnology ; Women's Health/statistics & numerical data
    Keywords covid19
    Language English
    Publishing date 2020-08-17
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 2452514-5
    ISSN 1941-6636 ; 1559-0739 ; 1941-6628 ; 1537-3649
    ISSN (online) 1941-6636 ; 1559-0739
    ISSN 1941-6628 ; 1537-3649
    DOI 10.1007/s12029-020-00472-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Sugar Sweetened and Artificially Sweetened Beverage Consumption and Pancreatic Cancer: A Retrospective Study.

    Davis, Evan W / McCann, Susan E / Joseph, Janine M / Yeary, Karen H K / Fountzilas, Christos / Moysich, Kirsten B

    Nutrients

    2023  Volume 15, Issue 2

    Abstract: Pancreatic cancer (PanCa) is a highly fatal malignancy with few modifiable risk and prognostic factors. This study investigates the association between cola, diet cola, and non-cola soft drink consumption and PanCa risk and mortality. A retrospective ... ...

    Abstract Pancreatic cancer (PanCa) is a highly fatal malignancy with few modifiable risk and prognostic factors. This study investigates the association between cola, diet cola, and non-cola soft drink consumption and PanCa risk and mortality. A retrospective study was conducted using data from the Patient Epidemiology Data System (1982-1998) at Roswell Park Comprehensive Cancer Center (Buffalo, NY, USA), including 213 PanCa patients and 852 cancer-free controls. Data were collected using a self-administered questionnaire, including a 46-item food frequency questionnaire (FFQ). Multivariable logistic regression was used to estimate odds ratio (OR) and 95% confidence interval (CI) of cola, diet cola, and non-cola soft drink consumption and PanCa risk. Cox proportional hazard regression was used to estimate hazard ratios (HR) and 95% CIs of cola, diet cola, and non-cola soft drink consumption and PanCa mortality. Stratified analyses were conducted by sex, body mass index (BMI), and smoking status. We observed significant 55% increased odds of PanCa among patients consuming ≥1 regular cola per day (OR: 1.55, 95% CI: 1.01-2.39). We also observed non-significant 38% increased hazard of mortality among patients consuming ≥1 regular cola per day (HR: 1.38, 95% CI: 0.91-2.07). We conclude that regular cola consumption is a modifiable lifestyle that may be associated with PanCa risk and mortality following diagnosis.
    MeSH term(s) Humans ; Sugars ; Artificially Sweetened Beverages ; Sweetening Agents/adverse effects ; Retrospective Studies ; Risk Factors ; Prospective Studies ; Pancreatic Neoplasms/epidemiology ; Pancreatic Neoplasms/etiology ; Beverages/adverse effects ; Beverages/analysis ; Pancreatic Neoplasms
    Chemical Substances Sugars ; Sweetening Agents
    Language English
    Publishing date 2023-01-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu15020275
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Physical Activity and Patient-Reported Outcomes in Monoclonal Plasma Cell Disorders.

    Joseph, Janine M / Hillengass, Michaela / Sweeney, Nathan W / Molina, Thomas H / Ahlstrom, Jennifer M / Moysich, Kirsten / Cannioto, Rikki / Hillengass, Jens

    Medicine and science in sports and exercise

    2023  Volume 55, Issue 11, Page(s) 1952–1960

    Abstract: Introduction: Plasma cell disorders (PCD) are a group of conditions characterized by disproportionate proliferation of a single clone of B lymphocytes. Multiple myeloma (MM) is a malignant type of plasma cell disorders. Improvements in MM survival have ... ...

    Abstract Introduction: Plasma cell disorders (PCD) are a group of conditions characterized by disproportionate proliferation of a single clone of B lymphocytes. Multiple myeloma (MM) is a malignant type of plasma cell disorders. Improvements in MM survival have led patients and physicians to pursue strategies to improve quality of life for those living longer with this disease. Bone disease and instability associated with MM have made physicians reluctant to recommend physical activity (PA) to this patient population. The goal of this study was to examine the relationship between PA and physical and psychosocial patient-reported outcomes in patients with MM and precursor conditions.
    Methods: We used a cross-sectional study design. Questionnaires on PA, demographics, fatigue, distress, and other aspects of quality of life were posted on the HealthTree® Cure Hub website, a patient portal through which individuals with MM and related disorders obtain support, track laboratories and other information about their diseases, and participate in research.
    Results: A total of 794 individuals, including 664 with MM, are included in the current analysis. We observed potential inverse associations between PA and poor quality of life, including problems with sleep, fatigue, neuropathy, distress, and several psychosocial states. On average, patients reported that their PA levels have declined since diagnosis and that they would like to be even more active in the future than they were before their diagnosis.
    Conclusions: In our cross-sectional study, regular PA was associated with multiple quality-of-life indicators and other patient-reported outcomes, including better sleep and less fatigue, neuropathy, and distress. The findings of this study can help guide the design of prospective studies of the role of PA in MM survivorship.
    MeSH term(s) Humans ; Quality of Life ; Prospective Studies ; Cross-Sectional Studies ; Plasma Cells ; Exercise/psychology ; Fatigue/psychology
    Language English
    Publishing date 2023-07-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603994-7
    ISSN 1530-0315 ; 0195-9131 ; 0025-7990
    ISSN (online) 1530-0315
    ISSN 0195-9131 ; 0025-7990
    DOI 10.1249/MSS.0000000000003246
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Call for Epidemiological Research on Myeloid-Derived Suppressor Cells in Ovarian Cancer: A Review of the Existing Immunological Evidence and Suggestions for Moving Forward.

    Stenzel, Ashley E / Abrams, Scott I / Moysich, Kirsten B

    Frontiers in immunology

    2019  Volume 10, Page(s) 1608

    Abstract: Recently, there have been encouraging findings suggesting that myeloid-derived suppressor cells (MDSCs) may be a good target for studying immune suppression in ovarian cancer. MDSCs are an abundance of immature myeloid cells that have demonstrated the ... ...

    Abstract Recently, there have been encouraging findings suggesting that myeloid-derived suppressor cells (MDSCs) may be a good target for studying immune suppression in ovarian cancer. MDSCs are an abundance of immature myeloid cells that have demonstrated the ability to decrease tumor-infiltrating immune cells, increase the accrual of tumor-associated macrophages and regulatory T cells, as well as secrete various pro-inflammatory mediators and growth stimulating cytokines. Most studies on this topic utilized murine models, but there are limited reports in human subjects which have important limitations. With the majority of ovarian cancer patients presenting with distant metastases and a corresponding 5-year relative survival rate of < 30%, continued efforts are obligatory toward identifying potential prognostic factors. Given the difficulty of studying exposures in this patient population, as well as the existing immunologic characteristics of this cancer, there is growing interest in further identifying genetic and immunologic associations with patient survival. Furthermore, prognostic factors that may necessitate therapeutic intervention may significantly alter disease outlook. In this review paper, we address the current literature on MDSCs and their immunosuppressive behavior in ovarian cancer patients. While the previous studies on these cells in ovarian cancer have demonstrated some potential prognostic significance, there are many limitations to such studies including small sample sizes, inconsistent staging and histology, as well as inconsistent surface markers for the identification of MDSCs. Additionally, such studies include minimal patient characteristics involved with the clinical course of ovarian cancer. Here, we have proposed improving on studies analyzing MDSCs as a potential prognostic factor in ovarian cancer patients, as well as further identifying the potential of this novel prognostic factor in future care, through the use of a comprehensive epidemiologic model.
    MeSH term(s) Animals ; Biomarkers ; Disease Susceptibility/immunology ; Epidemiologic Studies ; Evidence-Based Medicine ; Female ; Humans ; Interferon Regulatory Factors/metabolism ; Mice ; Myeloid-Derived Suppressor Cells/immunology ; Myeloid-Derived Suppressor Cells/metabolism ; Ovarian Neoplasms/epidemiology ; Ovarian Neoplasms/etiology ; Ovarian Neoplasms/metabolism ; STAT Transcription Factors/metabolism ; Tumor Escape ; Tumor Microenvironment
    Chemical Substances Biomarkers ; Interferon Regulatory Factors ; STAT Transcription Factors ; interferon regulatory factor-8
    Language English
    Publishing date 2019-07-09
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2019.01608
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry.

    Stenzel, Ashley E / Buas, Matthew F / Moysich, Kirsten B

    Cancer epidemiology

    2019  Volume 62, Page(s) 101580

    Abstract: Objective: Update information on racial disparities in ovarian cancer survival from the Surveillance, Epidemiology, and End Results (SEER) Program.: Methods: Data on women with epithelial ovarian cancer from the SEER Program between 1995-2015 were ... ...

    Abstract Objective: Update information on racial disparities in ovarian cancer survival from the Surveillance, Epidemiology, and End Results (SEER) Program.
    Methods: Data on women with epithelial ovarian cancer from the SEER Program between 1995-2015 were collected including; patient ID, age at diagnosis, year of diagnosis, surgery, chemotherapy, radiation, insurance status, region of registry, tumor grade, tumor histology, tumor summary stage, survival months, race/ethnicity, and vital status. Multivariable analyses were performed to examine overall survival, differences in survival by age at diagnosis, by year of diagnosis, risk of not receiving surgery, and risk of 12-month death across racial/ethnic groups.
    Results: Non-Hispanic black women (n = 4261) had an increased risk of overall mortality (HR = 1.28, CI: 1.23-1.33) when compared to non-Hispanic white women (n = 47,475), which appears more pronounced among women diagnosed under age 50. Hispanic women (n = 7052) had no difference in survival when compared to non-Hispanic white women (HR = 1.03, CI: 0.99-1.07). Non-Hispanic Asian/PI women (n = 5008) exhibited slightly reduced risk (HR = 0.95, CI: 0.91-0.99) when compared to non-Hispanic white women. Risk of not receiving surgical intervention remains high among non-Hispanic black women and Hispanic women, when compared to non-Hispanic white women. Non-Hispanic black women, non-Hispanic Asian/PI women, and Hispanic women were all at significantly greater risk of dying within the first 12 months of cancer diagnosis when compared to non-Hispanic white women.
    Conclusion: Disparities in survival remain across various racial/ethnic groups, when compared to non-Hispanic white women with ovarian cancer. These disparities should continue to be examined in an effort to decrease such gaps.
    MeSH term(s) Carcinoma, Ovarian Epithelial/ethnology ; Carcinoma, Ovarian Epithelial/mortality ; Ethnic Groups ; Female ; Humans ; Middle Aged ; Registries ; SEER Program/standards ; Survival Analysis
    Language English
    Publishing date 2019-08-07
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2508729-0
    ISSN 1877-783X ; 1877-7821
    ISSN (online) 1877-783X
    ISSN 1877-7821
    DOI 10.1016/j.canep.2019.101580
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: T Cell Exhaustion Markers in Multiple Myeloma Patients are Lower After Physical Activity Intervention.

    Joseph, Janine M / Hillengass, Michaela / Cannioto, Rikki / Tario, Joseph D / Wallace, Paul K / Attwood, Kristopher / Groman, Adrienne / Jacobson, Hillary / Wittmeyer, Bryan / Mohammadpour, Hemn / Abrams, Scott I / Moysich, Kirsten B / Hillengass, Jens

    Clinical lymphoma, myeloma & leukemia

    2024  

    Abstract: Purpose: There is compelling evidence that CD4: Patients and methods: The current study includes 24 multiple myeloma patients who participated in a six-month physical activity intervention, consisting of supervised strength training (n = 12) and ... ...

    Abstract Purpose: There is compelling evidence that CD4
    Patients and methods: The current study includes 24 multiple myeloma patients who participated in a six-month physical activity intervention, consisting of supervised strength training (n = 12) and unsupervised home-based walking arms (n = 12). Comprehensive flow cytometry was utilized to assess the frequency of CD4
    Results: Eighteen of 20 exhaustion measures were lower at the end of the intervention than at baseline, and several were significantly or borderline significantly reduced in the entire sample or in one of the arms. The entire sample saw improvements in the ratios of CD4
    Conclusions: This pilot study suggests that physical activity induces changes in MM patients' immune systems, potentially rendering a less exhausted T cell state.
    Language English
    Publishing date 2024-04-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2540992-X
    ISSN 2152-2669 ; 2152-2650
    ISSN (online) 2152-2669
    ISSN 2152-2650
    DOI 10.1016/j.clml.2024.04.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Clinical needs for transgender men in the gynecologic oncology setting.

    Stenzel, Ashley E / Moysich, Kirsten B / Ferrando, Cecile A / Starbuck, Kristen D

    Gynecologic oncology

    2020  Volume 159, Issue 3, Page(s) 899–905

    Abstract: Transgender men remain at risk for gynecologic malignancies, but are an underserved population. Members of the transgender community experience discrimination and have experiences that contribute to health disparities, including in gynecology and ... ...

    Abstract Transgender men remain at risk for gynecologic malignancies, but are an underserved population. Members of the transgender community experience discrimination and have experiences that contribute to health disparities, including in gynecology and oncology. While efforts have been made within the United States to reduce inequalities experienced by members of this community, many needs in the clinical setting remain. Increased education and training among providers and healthcare professionals, and general improvements towards understanding barriers to health screening and health resource uptake may reduce some disparities. Additional research towards screening and cancer surveillance among this community will be necessary to understand any potential additional risks and survival disparities experienced by transgender men. This review focuses on barriers and clinical needs for transgender men in the gynecologic oncology setting, and suggestions for moving forward to improve care for this patient population.
    MeSH term(s) Female ; Genital Neoplasms, Female/diagnosis ; Genital Neoplasms, Female/therapy ; Gynecology/organization & administration ; Gynecology/statistics & numerical data ; Health Services Needs and Demand/statistics & numerical data ; Healthcare Disparities/statistics & numerical data ; Humans ; Male ; Mass Screening/organization & administration ; Medical Oncology/organization & administration ; Medical Oncology/statistics & numerical data ; Quality Improvement ; Social Stigma ; Transgender Persons/statistics & numerical data ; United States ; Vulnerable Populations
    Keywords covid19
    Language English
    Publishing date 2020-09-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 801461-9
    ISSN 1095-6859 ; 0090-8258
    ISSN (online) 1095-6859
    ISSN 0090-8258
    DOI 10.1016/j.ygyno.2020.09.038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top